Posted on

Abacavir + Lamivudine [120 mg / 60 mg dispersible tablet] for the treatment of human immunodeficiency virus (HIV) infection in pediatric population

Cycle 2 | Drugs

HTA Council Recommendation (as of 26 November 2024)

The HTA Council positively recommends Abacavir + Lamivudine [120 mg / 60 mg dispersible tablet] for the treatment of human immunodeficiency virus (HIV) infection in pediatric population for the inclusion in the PNF and thus the government financing of the said health technology.

Relevant Information

  • Status: With Final HTA Council Recommendation with SOH Decision
  • Topic Assignment: Internal Assessment
  • Policy Question: Should Abacavir + Lamivudine [120 mg / 60 mg dispersible tablet] for the treatment of human immunodeficiency virus (HIV) infection in pediatric population be funded by the government?

Evidence and Relevant Documents

Back to Assessments Page